Contact – +1-276-477-5910
 Email –

Home >> Latest Press Release



Healthcare BPO Market by Services (Revenue cycle management, Patient enrollment, Medical coding, billing and collection services), by facility (Large health systems, Stand-alone hospitals, Ambulatory surgical centers) - Global Industry Trends & Forecasts Upto 2023

The healthcare BPO market is estimated to reach USD 330 billion by 2023 growing at a CAGR of 11.0 from 2018-2023. The healthcare BPO market is primarily driven by elevating cost-saving factor, growing perception for recovery audits coupled with increasing research and development activities. However, the service reliability issue along with the complications and concerns of data privacy may hamper the growth of this market. In addition, implementation of IT in Healthcare sector serve to be the growing opportunity for healthcare BPO market. The adoption of BPO services is also responsible for propelling the growth of the market. The healthcare BPO market can be segmented into payer services, provider services, and pharmaceutical services. The payer services can be further segmented into human resource management, claims management, Customer Relationship Management (CRM), operational/administrative management, product development, care management and provider management. The induced pressure to reduce elevating Healthcare expenditures, increasing demand of niche services, increasing demand of ICD-10 over ICD-9, adoption of automation and integrated sourcing strategies and demand and recovery audits are some of the prime factors responsible for propelling the growth of this market. The provider services of healthcare BPO market provider is further segmented into patient enrollment and strategic planning, medical billing, medical transcription, device monitoring and revenue cycle management. On the basis of provider service, revenue cycle management is expected to grow at a steady pace during the forecast period. The growing revenue cycle management market further counts to the decreasing reimbursements in the healthcare industry, resulting in the reduction of overall Healthcare expenditure coupled with supportive government policies fuels the growth of this segment in Healthcare BPO market. The Pharmaceutical segment of this market is further classified into manufacturing outsourcing, clinical data management, and pharmacovigilance services. Factors like increasing research and development activities, strict norms, adoption of IT in the healthcare sector, and upsurge demand in RCM plays a significant role in fueling the growth of the market. However, the lack of proper and accurate information and Communication Technology infrastructure coupled with interoperability issues and lack of domain expertise may restrict the growth of the market. Geographically, the healthcare BPO market segmented into North America, Europe, Asia, and ROW. On the basis of geography, North America dominates this market, accounting to the growing economic growth rate and increasing Healthcare expenditure throughout this region. This further resulted in increasing investments in Technologies responsible for simplifying the healthcare systems and services that further drive the growth of this market. Moreover, the adoption of BPO services in the healthcare industry, increase in medical transcription outsourcing services and adoption of cloud-based BPOs healthcare sector are for the responsible in creating great opportunities for this market. However, the increasing doubts over the quality of services, high attrition rate, and privacy concerns and data security issues may restrict the growth of the market. The key players operating in this industry are Accenture, Tata Consultancy Services, Genpact, Boehringer Ingelheim GmbH, Cognizant, Charles River Laboratories International Inc., Covance Inc., Infosys Limited, Lonza Group Ltd. and Quintiles Inc. ...

 3/27/2018 |  Healthcare

eClinical solutions Market By Product (Electronic Data Capture and Clinical Data Management Systems Clinical Trial Management Systems), By (Phase I, Phase II, Phase III, Phase IV)-Global Trends & Forecasts Upto 2023

The e-clinical solutions market is estimated to account for USD X.X billion in 2017, and is projected to grow at a CAGR of X.X% to reach USD X.X billion by 2023. The market is majorly driven by the increasing count of clinical trials, rising number of government funding for such trials, growing need for improved data standardization, regulatory requirements associated with clinical research studies and increasing research and development of activities by pharmaceutical and biotechnology based companies. In addition, the adoption of global software solutions in clinical research studies, access data mounting from Healthcare industry and the presence of wide and strong range of products in the pipeline are another factors that boost the growth of this market. However, the lack of awareness about the benefits of a clinical solution coupled with the infrastructure of these solutions are the prime factors hindering the growth of the market. Additionally, the lack of skilled professionals and high implementation cost associated with the e-clinical solution software also restricts the demand for e-clinical solutions. Moreover, the factors like growing clinical Research activities in developing region coupled with the outsourcing of clinical trial processes are expected to create more opportunities for this market. But, the software reliability issues and patient privacy concerns still serves to be the major challenges of e-clinical solutions market. The e-clinical solutions market is segmented on the basis of product, type, delivery model, phase of clinical trials, end-users and region. On the basis of products, the market is fragmented into Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, Biostatistics and statistical programming solutions, Data conversion and standardization solutions, Electronic patient reported outcome solutions, e-clinical integration solutions, and Other e-clinical Solutions. On the basis of types, the e-clinical solutions market is categorized into standalone and integrated systems. Whereas on the basis of delivery models, this market is fragmented into on-premises e-clinical solutions and on-demand or cloud-based e-clinical solutions. The on-demand e-clinical solution segment is growing at a faster rate, accounting to the increasing applications of internet of things, real time study management, adoption of standard and ad hoc reporting, etc. On the basis of phase of clinical trials, this market is categorized into Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, and Phase IV Clinical Trials. Whereas, the end-user category comprises of pharmaceutical and bio-pharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, and hospitals. Among all, the pharmaceutical and bio-pharmaceutical companies is expected to dominate this market, owing to the increasing research and development activities for new product development, adoption of a centralized place to carry out all the trials related information and the improvement in clinical data management by the involvement of staff and data administrators. Geographically, the market is segmented into North America, Europe, Asia and ROW. North America dominate this market, accounting to the elevating count of clinical trials, increasing research and development activities for the development of new product, supportive government policies and changing lifestyles. However, the Asian region is also reported to have a steady growth rate during the forecast years, owing to the increasing research and development activities in this region. The key players operating in this industry are BioClinica, CRF Health, Datatrak International, Inc., Medidata Solution, Inc., Merge Health Incorporated, OmniComm Systems Inc., Oracle Corporation, and Parexel International Corporation. ...

 3/27/2018 |  Healthcare

Healthcare Analytics Market, Type (Prescriptive, Predictive, Diagnostic), Component (Hardware, Software, Services), Application (Financial, Clinical, Population Health Management), End- User (Payers, Providers, ACOS) - Global Market Trends & Forecasts upto 2023

The healthcare analytics market is estimated projected to grow at a CAGR of 28.0 % to reach USD billion by 2023. High adoption rates of electronic health record systems coupled with the application of big data in healthcare and increasing investment expenditures in healthcare industry is also boosting the growth of healthcare analytics market. However, the lack of skilled IT professionals coupled with the penetrating data integrity issues are the major restraints of healthcare analytics market. In addition, the implementation and applications of electronic health records, focus on value-based medicines and growing adoption of cloud-based analytics serve to be the prime opportunities for this market. The healthcare analytics market can be segmented on the basis of type, component, delivery mode, application, and end-user. On the basis of type, the healthcare analytics market can be segmented into descriptive analytics, diagnostic analytics, predictive analytics, and prescriptive analytics. The descriptive analytics segment, on the basis of types of healthcare analytics market, is reported to have the largest market share, owing to the increasing supportive and favorable healthcare policies that are launched by the government, progressive outcomes of clinical processes and the positive impact of social media on the healthcare industry. On the basis of components, the healthcare analytics market can further be segmented into services, software, and hardware. The services segment is further categorized as support services and business analytics services; whereas the software segment is further divided into standalone and integrated. Based on components of Healthcare analytics market, the services segment holds the largest market share accounting to the elevating need for business analytics services coupled with the advancements in technical healthcare analytics software. In addition, the emerging requirement of personalized and evidence-based medicine is also responsible for increasing the demand for service-based healthcare analytics software in the market. On the basis of delivery mode, this market is further categorized as on-premise healthcare analytics and on-demand /cloud healthcare analytics. On the basis of the delivery model of healthcare analytics market, the on-demand healthcare analytics segment is expected to grow at a steady pace; accounting to the higher flexibility, upsurge need for self-driven analytics, and pay-as-you-go cost factor. Moreover, the lack of increasing capital investments in the healthcare sector is also responsible for fuelling the growth of this market. On the basis of application, the market is fragmented into financial analytics, clinical analytics, operational and administrative analytics, and population health management/analytics. On the basis of applications of Healthcare Analytics market, operational and Administrative Services dominated this market in 2015, accounting to the elevated count of application including strategic Analytics, supply chain management and workforce. However, the financial applications are also expected to have an anticipated growth during the forecast, owing to the increasing adoption of Healthcare analytics in both governments as well as private healthcare departments. Lastly, on the basis of end-users, the healthcare analytics market is segmented into payers, providers, ACOS, HIES, MCOS, and TPAS, and third-party business analytics service providers. On the basis of end users, the payers segments are expected to dominate this market during the forecast years, accounting to the involvement and application of these services quality improvement, population health management, and personalized care. However, the increasing efficiency in Healthcare sector coupled with the reduction in the unnecessary and unwanted expenditure is also responsible for dominating this segment. Geographically, the market is divided into North America, Europe, Asia, and ROW. Geographically, North America dominates the Healthcare analytics market followed by Europe and Asia; accounting to the technological advancements in Healthcare services, implementation of regulatory clauses, and increasing government incentives that are focusing on the manufacturing and applications of personalized and customized medicines. However, the expensive nature of analytics software and services, increasing data integrity issues, the complexity of software and intensified competition may hamper the growth of Healthcare analytics market. The key players operating in this industry are Cognizant, Health Catalyst, IBM, Mede Analytics, Inc., MedAssets, Inc., McKesson Corporation, Optum, Oracle, Inc., SAS Inc., Truven Health Analytics, and Verisk Health. ...

 3/27/2018 |  Healthcare

Infection Control Market By Type (Disinfectants, Sterlization, Medical Non-Wovens, Disinfectors), End-User (Hospitals, Medical Devices, Pharmaceuticals, Life Science Industry, Clinical Laboratories, Food Industry - Global Market Trends & Forecasts Upto 2023

The Infection Control market is estimated 25 billion by 2025 growing at a CAGR of 6.0 % from 2018-2025. Factors like increasing prevalence of hospital acquired infections, elevating count of surgical procedures, strict safety norms and regulations, and technical advancements in sterilization processes search to be the driving factors of this market. However, sterilization of advanced medical instruments and increasing concern related to safety of reprocessed instruments hamper the growth of this market. Additionally, high adoption rate of E-beam sterilization and merger of pharmaceutical and medical device manufacturer are also boosting the growth of the infection control market, globally. Moreover, the non-compliance issues by the end users with respect to the sterilization standards is the prime challenging factor for this market. The infection control market is segmented on the basis of products & services, end user and geography. On the basis of products & services, the market is further fragmented into sterilization products and services, disinfectants, medical non-woven and disinfector. Among all, the disinfection segment holds the largest market share, owing to the growing application of infection control systems in hospitals, the growing need for reduction of cross contamination in food and Pharmaceutical sectors and the high adaptability rate of skin and hand disinfectants. Additionally, the infection control market is also segmented on the basis of end-user, as hospitals, medical device companies, pharmaceutical companies, life science industry, clinical laboratories, food industry and others. Hospital segment dominates this market, accounting to the increasing prevalence of hospital acquired infections, elevating health related expenditures due to the increasing count of elderly population and chronic diseases. Moreover, the threat of infectious diseases like AIDS, Ebola and antivirus in the last 3 decades is also responsible in fueling the growth of the market. On the basis of geography, North America dominates this market, followed by Europe, Asia and ROW. The increasing demand for infection control products, growing awareness about hygiene and infection free environment coupled with increasing count of surgical processes also plays an important role in propelling the growth of infection control market in North America. In addition, the supportive government policies, changing lifestyles and growing geriatric population further increases the demand for infection control systems. Asian region is also expected to have a study growth during the forecast years, accounting to the growing economies of developing countries like India and China, increasing prevalence of nosocomial infections coupled with the improvement and expansion of healthcare infrastructure of this region. However, the growing outsourcing trend by the established key players of developed regions to the company's present in Asian regions is also responsible in boosting the growth of infection control market. The key players operating in this industry are 3M Company, Ahlstrom Corporation, Belimed AG, Cisa S.p.A, Getinge Group, Honeywell International, Inc., Johnson & Johnson Limited, Kimberly-Clark Corporation, Matachana Group, Nordion Inc., Sakura Global Holding Company Ltd., Sterigenics International, Inc., STERIS Corporation, Synergy Health plc, and TSO3 Inc. ...

 3/27/2018 |  Healthcare

Software Defined Everything Market By Type (Software-Defined Networking, Software Defined Data Centre, Software Defined Computing, Software Defined Storage), Services (Managed, Consulting, Integration and Deployment), Vertical (IT, Telecom, Healthcare, BFSI, Manufacturing, Logistics) - Global Trends & Forecasts Upto 2025

Software Defined Everything (SDE) specifies the shift of technology in software defined way for accessing the storage, networks and data centers. The main function of SDE is to reduce the silos in the market. Software defined everything is segmented on the basis of type and application. The type segment is further bifurcated into SDN, SDS and SDDC. SDN offers a great amount of flexibility and more control over the programs and how the data packets and traffic travels across your network. Cloud Computing plays vital role in the development and growth of SDE and SDN (Software defined networking). Many IT companies are adopting cloud computing in the network infrastructure for the better and efficient management. SDN helps in allowing the cloud service providers to host multiple number of virtual networks without any need of common separation isolation methods. The SDE Market is expected to grow at a CAGR of 28% during the forecast period 2017–2023. The SDE market is driven by IoT and cloud computing adoption across industry verticals such as BFSI, aerospace & defense, retail, food & beverages, healthcare and automotive. The major players included in this report are Dell, HPE, VMware, Extreme Networks, Nexenta Systems, Riverbed Technology, Silver Peak, Metaswitch Networks, Pivot3, Infoblox and others. This report offers major trends, industry trends which is going to play a major role in SDE market during the forecasted year. Moreover, this report can also tailored as per the requirement by the users, and also available with deeper segmentation by regions, countries, and vendor profiling. ...

 3/27/2018 |  ICT

District Cooling Market, By Technique (Free Cooling, Electric Chiller, Absorption Cooling), Application (Residential, Commercial, Industrial) - Global Market Trends & Industry Forecasts Upto 2023

The total district cooling market is valued at $ 5.6 billion as on 2018 and is likely to reach $ 10.23 billion by the end of 2023, growing at a CAGR of 14.1%. The district cooling market is will bolstered as it offers various benefits such as it helps in capital cost savings by 8%, around 50% reduction of electric power consumption and reduction of CO2 and refrigerant emissions by 60-70% and good operational efficiency as compared to other cooling technologies when it used in highly dense areas. The factors driving the district cooling market are energy efficient cooling technology. Recently, United Nations has considered district cooling as the most energy efficient technology as it aids in preserving energy and water. The major issues faced in this market are risk of early investments, and initial high capital costs. In 2018, the district cooling market is dominated by Middle East & Africa market followed by North America and then Asia-Pacific. The Middle East will experience the highest growth rate during the forecast period as district cooling offers various advantages such as high cooling density, more cost efficient than conventional cooling, more energy efficient, no harmful impact on the environment. By 2030, if district cooling is properly employed, then it can fulfill 30% cooling needs of GCC countries. The district cooling market has been segmented on the applications i.e. residential, commercial and industrial. In 2018, the residential segment will experience high growth in the next five years where as commercial segment will account for the highest growth rate. The commercial segment will experience the highest growth rate due to increasing demand of district cooling in hotels, molls etc. The growth in district cooling market is influenced by investments and major expansion plans. In 2018, UAE based National Central Cooling Company (Tabreed) and the Masdar Institute of Science and Technology, completed three years R& D project in district cooling plant. Some of the prominent players in the market are Empower, National Central Cooling Company PJSC (Tabreed), Semens AG, District Cooling Company LLC, Qatar Coolol, Danfoss District Energy A/S, ADC ENERGY SYSTEMS LLC, Keppeldchs PTE Ltd, Marafeq Qatar, Logstor. ...

 3/2/2018 |  Chemicals & Materials

Bio-Fertilizers Market, By Type (Nitrogen Fixing, Phosphate Solubilizing, Potash Mobilizing), Application (Seed, Soil), Crop Type (Fruits & Vegetables, Cereals & Grains, Pulses), Microorganism (Azotobacter, Azospirillium & Others) – Global Market Trends & Forecasts Upto 2023

The total bio-fertilizers market is projected to witness a growth rate of 14.2% from 2017-2023. The market is expected to reach $ 2.8 billion by 2023. Increasing awareness about maintaining soil fertility and adopting environmentally friendly techniques is a major factor behind the bio-fertilizers market growth. There are many benefits associated with bio-fertilizers such as less soil & water contamination, better endurance with seeds & soil, increasing the range of nutrient absorption in soil, etc. Soil fertility management techniques have received certain importance due to the rising demand for food and the loss of arable land, globally. Severe health impacts as well as contamination of soil, water, and air have been observed due to the use of synthetic or chemical fertilizers. Such hazardous impacts of synthetic fertilizers and the growing demand for food boosts the market growth of bio-fertilizers. In 2017, Cyanobacteria is the most popular segment in terms of microorganisms, which accounted for the largest market share in the bio-fertilizers market. Cyanobacterial bio-fertilizer harnesses basic natural inputs such as nitrogen, water, and solar energy to ensure as well as enhance soil fertility and plant growth. Phosphate soluble bacteria are expected to witness the fastest growth during the forecast period, due to its need to increase the P2O5 content in soil. By crop type, cereals and grains was observed as the leading segment as it constitutes the basic food elements of people. In terms of form of bio-fertilizers, liquid formulations that consist of the desired micro form of nutrients, organisms, etc., which promotes the formation of resting spores, was the largest market segment in 2017. Liquid bio-fertilizers are forbearing to UV radiations and high temperature. They have a shelf life of approximately two years, which are applied using fertigation tanks, hand sprays, etc. The liquid bio-fertilizer is projected to witness the highest growth rate during the forecast period due to high enzymatic activity and high acceptance rate amongst consumers. North America was the largest market for bio-fertilizers in 2017. The growing awareness of consumers regarding harmful health impacts caused due to chemical fertilizers and the growing culture of organic farming drive the market growth in the region. The ban of certain chemicals such as glyphosate, atrazine, chlorpyrifos, 2,4-D, etc., has stimulated the requirement of bio-fertilizers in the region. Asia-Pacific has adopted environmentally friendly techniques of farming. However, a dearth of knowledge and awareness as well as availability of low cost chemical fertilizers limits the usage of bio-fertilizers in several countries of Asia-Pacific. Companies across the globe are spending extensively on R&D to provide their customers with beneficial bio-fertilizers. Some of the leading manufacturing companies include Biomax, Camson Bio Technologies Limited, Gujarat State Fertilizers & Chemicals Ltd, Lallemand Inc, Madras Fertilizers Limited, Novozymes A/S, National Fertilizers Limited , Nutramax Laboratories, In, Rizobacter Argentina S.A., Rashtriya Chemicals & Fertilizers Ltd., T.Stanes & Company Limited, Agri Life, CBF China Bio-Fertilizer AG, Kiwa Bio-Tech Products Group Corporation, Krishak Bharati Cooperative, & others....

 3/2/2018 |  Food & Beverage

Building Thermal Insulation Market, By Material (Plastic Foam, Glass Wool, Stone Wool, Polystyrene Foam, Polyurethane Foam), Building Type (Residential, Non-Residential), Application (Pitch Roof, Flat Roof, External Walls, Internal Walls, Floor, Cavity Wall) - Global Market Trends & Forecasts Up to 2025

The building thermal insulation market is estimated to account for USD 25.8 billion in 2017, and is projected to grow at a CAGR of 3.25% to reach USD 31.2 billion by 2023. Stringent regulations pertaining to reduction of GHG emissions in North America and Europe are primarily driving the building thermal insulation market. The opportunities for players in the BTI market lies in exploring the untapped market in the emerging economies and launching better energy efficient products. [<<img 3.png>>] In the building thermal insulation market, with respect to materials, plastic foams is the leading segment. Its demand is prominent in the Asia-Pacific market along with significant consumption in the European countries. The superior properties of plastic foams, such as low thermal conductivity, high strength, and lifespan, and versatility have been driving its demand over the years. Among the varieties of plastic foams, Expanded polystyrene (EPS) is expected to be the fastest growing segment with a CAGR of 4.0-4.5% for the next five years until 2023. Low thermal conductivity (high R-value) of EPS’ enables the manufacturers to use it in lower quantities to make products of similar thermal resistance in comparison to other insulation materials. In addition, EPS’ durability and lightness is driving its demand in the European and the North American market. In 2017, Wool insulation accounts for the second largest share in the BTI market by materials. It is estimated to account for about 40.0% of the total building thermal insulation market in terms of value. Wool insulation products such as blankets & sheets are the widely used as they possess temperature sustaining capacity up to 4100 C and thickness varying from 25 to 150 mm. In the coming years, glass wool is anticipated to be the leading material in this segment. Glass wool’s demand is high due to its increasing usage in masonry cavity walls, flat roofs, and suspended floor insulations owing to low inflammability. In 2017, Wall insulation accounted for the highest share among roof and floor applications, and is expected to continue to dominate during the forecast period. The walls have the large surface area and maximum dissipation of energy takes place through walls in a building, thus driving the demand for wall insulation. Roofs account for the second largest share as it is the prominent source of heat penetration from direct sunrays and proper insulation is required to maintain optimal temperatures. Residential building segment is estimated to account for about 55.0% of the total building thermal insulation market in 2017. However, the non-residential segment is anticipated to account for the rest 45.0% of the total BTI market value. The presence of strict building codes, accompanied by the growing demand for housing sector especially in the US, the UK, and Germany drive the demand for building thermal insulation in residential buildings. The non-residential segment is expected to witness high growth than residential segment during the forecast period. Increasing activities in the industrial and the manufacturing segment in the U.S. is expected to drive the demand for building thermal insulation in the non-residential segment in North America. The rising energy cost drives the demand for building thermal insulation in both residential and non-residential segment. In 2017, North America accounted for the largest share in the building thermal insulation market followed Europe and then Asia-Pacific. The building thermal insulation market in North America and Europe is driven by the stringent building codes, and the growth of housing sector primarily in U.S., the U.K. and Germany. An initiative like Weatherization Assistance Program (WAP) to focus adoption of thermal laggings in low income households at a large scale has boosted the North American building thermal insulation market. The insulation market in Europe is mostly dependent upon retrofit and renovation activities leading to re-insulation of old buildings. In the Western European region, after Germany, Poland is the second largest market for building thermal insulation products. Asia-Pacific is anticipated to be the fastest growing market for building thermal insulation products during the forecast period i.e. from 2018-2013. Increasing construction spending in China, India, and Japan to improve infrastructure in addition to energy conservation initiatives is expected to drive the BTI market in the APAC region over the next five years. The building thermal insulation market is highly fragmented and competitive in nature with the presence of global, regional, and local players. Joint ventures, mergers, collaborations and partnerships, and new product launch are the most prominent strategies practiced in this market to strengthen the market position. For instance, Rockwool International announced its capacity expansion plans in December 2017, wherein, the company would be acquiring land in Sweden, Romania, and U.S. to establish three new production facilities. The key players operating in this industry are BASE SE, Kingspan Group Plc, Owens Corning, Saint-Gobain S.A., Rockwool International, Johns Manville Corporation, Paroc Group, and Knauf Insulation among others. ...

 3/2/2018 |  Chemicals & Materials

Anti-Counterfeit Packaging by Type (Security Labels, Hologram, RFID, Coding & Printing, Packaging Designs), Feature (Track & Trace, Overt, Covert, Forensic), End-User (Clothing Industry, Food & Beverage Industry, Consumer Industries, Cosmetics & Personal Care, Industrial, Automotive, Electronics) – Trends & Global Forecast to 2023 

The total anti-counterfeit packaging market was estimated is likely to reach $ 212 billion by the end of 2023, to grow at a CAGR of 14.3% from 2018-2023. The anti-counterfeit packaging market is expected to witness high growth due to the increasing demand for security of the brand identity by manufacturers globally. The increasing development in highly safe and secured packaging to be used in various end-use applications is expected to drive the market growth during the forecast period. Track and trace technology is a leading feature of the anti-counterfeit packaging market as it is used in a variety of applications. As complexities are involved during the manufacturing distribution process of several products, manufacturing companies consider traceability systems as the perfect fit to solve all counterfeit-related challenges. Covert anti-counterfeit packaging is highly desirable in the clothing and food industry as it fulfills the need for low cost security packaging. Security labels are expected to emerge as the most attractive market segment as it is highly useful in the FMCG sector to reduce the chances of product counterfeiting. Manufacturers have developed a sense of affinity towards RIFD technology, along with the U.S. Food & Drug Administration and Walmart emphasizing on the early adoption of Radio Frequency Identification (RFID) in pharmaceutical packaging to reduce counterfeiting efforts. Alien Technology is one of the prominent manufacturers of RFID and Ultra High Frequency (UHF) products and services. Manufacturers have been increasing their investments in the R&D of RFID devices to introduce more cost-effective and secure RFIDs. The hologram segment is expected to grow at a robust rate during the forecast period as they are highly favored for anti-counterfeit packaging in beauty & cosmetic products and personal care products. The holographic strips help seal the packaging and cannot be removed without damaging the holographic surface. North America led the anti-counterfeit packaging market in 2017, followed by Europe and Asia-Pacific. North America is highly fragmented due to the presence of a large number of international and domestic players. Asia-Pacific is expected to attain the highest growth rate at a CAGR from 2018-2023. The major drivers for the APAC market are the rising concerns regarding the indemnities incurred by the production of forged products. China is home to a large number of pharmaceutical product manufacturers who are increasing the adoption of such anti-counterfeit packaging technologies in China. Huge investments and R&D are required in the anti-counterfeit market. The market exhibits the presence of a large number of players that have many patents to differentiate their own products and eliminate or reduce the threat of their competitors’ products in the market. In 2016, SICPA and Clariant together launched a new integrated protection for plastic pharmaceutical packaging and medical devices-PLASTWARD. Some of the major players of the market include 3M, Avery Dennison, AlpVision, Alien Technology, SICPA, Zebra, Amcor Technology, Authentix Inc., CCL Industries Inc., DuPont, Savi Technology, Tracelink Inc., Ampacet Corporation, Impinj, Inc., Advance Trace & Trace S.A., & others. ...

 3/1/2018 |  Chemicals & Materials

3D Printing Market, By Materials (Plastics, Ceramics and Glass, Metal and Alloys), End-User (Automotive, Aerospace, Defence, Education, Medical, Building, Construction and Architecture), Application (Tooling, Prototyping and Functional Materials Manufacturing), Technology (Steeolithography, Selective Laser Sintering, Polyjet and Fused Depostion Modeling) - Global Market Trends &Industry Forecasts Upto 2023

The total 3D Printing is likely to reach $ 34 billion by the end of 2023, growing at a CAGR of 27% from 2017-2023. The factors contributing towards the growth of 3D printing are easy manufacturing and heavy cost reductions, reduction of errors, optimum utilization of the raw materials, production of customized products, rising innovative raw materials for production and efficient use of production time and financials. A huge demand has been observed for precision machined components in a large range of end use industries. Currently, the 3D Printing market is expected to witness high growth as there is latent demand for easy creation of the complex design and geometries in certain industries as medical and dental. Also, the market is experiencing the increased competitive pressure for the investment in R&D as well as strong hunger for innovative printing materials and manufacturing techniques. In 2017, the 3D Printing market is dominated by North America followed by Europe and then Asia-Pacific. This growth in 3D Printing market is likely to occur due to growing applications of additive manufacturing in automobile, medical and consumer industry. The 3D printing technology in Defense industry particularly in USA will experience robust CAGR of 24% in the next five years mainly due to as 3D printing helps in reducing weight, leading to improved strength. The technology can produce highly complex parts as single-component systems. Easy printing spare parts and replacements 3D printing technology is natural fit for many defense applications. The Plastic segment accounted for the largest market share in 2017 and the category of other materials such as wax, paper, laywood, etc. are anticipated to witness the highest growth compelled by the increasing use of these materials in healthcare and medical industries. The various end-user industries of 3D Printing market are healthcare and medical, aerospace, automotive, defense and military, energy, education and others. The growing end use verticals such as wearable electronics, education and food and bakery will experience the highest CAGR from 2018-2023 whereas automotive, defense and healthcare and medical would be the largest market share owners during the forecast period. 3D bioprinting is developing very furiously as it is highly supported by the applications in In-Vitro Testing to discover new drugs as well as prototype printing of the organs and body parts. Huge investment has been done by the companies in 3D Printing Technology for example in 2016, GE has invested about $1.4 billion on buying two European 3D Printing companies Arcam AB from Sweden and SLM Solutions Group from Germany. This acquisition is expected to cut costs by US$3 billion to US$5 billion across the company, as the 3D technology could heavily reduce design and material costs and it is expected that company would purchase approximately 1,000 new 3D printing machines by the next decade. The major players in the 3D Printing market are 3D Systems, HP, Autodesk, Inc., Hoganas AB, Stratasys Ltd, Optomec, Inc., Arcam Group, The ExOne Company, Beijing Tiertime Technology, Nano Dimensions, Renishaw PLC, Voxeljet AG, Envisiontec GmbH, EOS GmbH, ARC Group Worldwide and other...

 2/27/2018 |  Semiconductors